Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
This piece explains the benefits of using rolling returns to assess index fund performance, highlighting consistency, cycles, and risk insights.
25,257 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A famous actress recently shared rare summer snapshots with her partner, highlighting how private moments can still s...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
Investors chasing AI growth need to connect revenue signals to real opportunity. This analysis compares Astera Labs a...
When high-growth fintech names stumble, markets react quickly. This piece breaks down Klarna’s Q4 miss, the stock mov...
D-Wave QBTS delivered a notable Q4 2025 run, with rising revenue and expanding services. This story breaks down what ...
A practical guide to understanding Fuel Tech (FTEK) in 2025. Learn what to watch in Q4 results, identify catalysts, a...
Mastercard launches a digital, AI-powered Virtual CFO to deliver CFO-grade guidance to small businesses, addressing a...
A small, steady rental portfolio can fuel early retirement. This article breaks down a boring, proven path to retire ...
Rumble's Q4 2025 results point to a shift from rapid growth to sustainable profitability. This article breaks down re...
Bluesky is carving a new path in social media by using an open, federated protocol. This article explains what Bluesk...
Microsoft’s 2018 GitHub acquisition is fueling a rapid AI flywheel, elevating Copilot Enterprise and Azure growth. A ...